Look Who’s On the Move!

Dr. Hubert Chen Joins ADARx Pharmaceuticals as Chief Medical Officer

SAN DIEGO--(BUSINESS WIRE)--ADARx Pharmaceuticals, Inc., a biotechnology company developing RNA-targeting therapeutics, today announced the appointment of Hubert C. Chen, M.D. as Chief Medical Officer. “We...

Repare Therapeutics Expands Executive Leadership Team with the Appointment of Philip Herman as EVP Commercial & New Product Development

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the appointment of...

Nationally Recognized Ophthalmologist Dr. Elizabeth Yeu Joins Avellino’s Board of Directors

MENLO PARK, Calif.--(BUSINESS WIRE)--Avellino Lab USA, Inc. (Avellino) today announced the appointment of Dr. Elizabeth Yeu to the company’s Board of Directors. Dr. Yeu...

Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO

SAN DIEGO--(BUSINESS WIRE)--Escient Pharmaceuticals, a clinical-stage company focused on discovering and developing novel, first-in-class therapies to address serious, unserved medical needs, today announced the...

DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the...

Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer

SAN FRANCISCO--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant...

Recent Articles

Get a free copy of "Cracking the Generics Code"

Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.